Oral terbinafine in toenail dermatophytosis. A double-blind, placebo-controlled multicenter study with 12 month's follow-up

Acta Dermato-Venereologica

Volumn 77, Issue 1, 1997, Pages 66-69

  Svejgaard, Else L ^a   Brandrup, Flemming ^b   Kragballe, Knud ^c   Larsen, Poul Ø ^d   Veien, Niels K ^d   Holst, Marianne ^e   Andersen, B O L ^d   Bro JØrgensen, Anne V ^d   Dahl, Jens C ^d   Frentz, Gerda ^d   Graudal, Charlotte ^d   Kamp, Peter ^d   Kroman, Niels ^d   Larsen, Finn S ^d   Mikkelsen, Flemming ^d   Munkvad, Jan M ^d   Olafsson, Jon H ^f   Rothenborg, Hans ^d   Staberg, Bent ^d   Søndergaard, Jørgen ^g   Thulin, Henning ^d   more..

^a Rigshospitalet   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d Private Dermatology Clinics   (Denmark)

^e Sandoz ^*  (Denmark)

^f REYKJAVIK UNIVERSITY   (Iceland)

^g BISPEBJERG HOSPITAL   (Denmark)

Author keywords

additional treatment; onychomycosis; short term treatment

Indexed keywords

PLACEBO; TERBINAFINE;

ARTICLE; CONTROLLED STUDY; DERMATOMYCOSIS; DERMATOPHYTE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAIL; ONYCHOMYCOSIS; PRIORITY JOURNAL; SIDE EFFECT; TOE; TRICHOPHYTON RUBRUM;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIFUNGAL AGENTS; DERMATOMYCOSES; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; NAPHTHALENES; ONYCHOMYCOSIS; TOES; TREATMENT OUTCOME;

EID: 8044242210     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Balfour JA, Faulds D. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992; 43: 259-284.
2. Villars V, Jones TC. Clinical efficacy and tolerability of terbinafine (Lamisil) - a new topical and systemic fungicidal drug for treatment of dermatomycoses. Clin Exp Dermatol 1989; 14: 124-127.
3. Villars V, Jones TC. Special features of the clinical use of oral terbinafine in the treatment of fungal diseases. Br J Dermatol 1992; 126(Suppl. 39): 61-69.
4. Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol 1992; 126(Suppl. 39): 23-27.
5. Scher RK. Onychomycosis is more than a therapeutic problem. Br J Dermatol 1994; 130(Suppl. 43): 15.
6. Roberts DT. Oral therapeutic agents in fungal nail disease. J Am Acad Dermatol 1994; (Suppl.) 31: 1: 78-81.
7. Gupta AK, Sauder DN, Shear NH. Antifungal agents: an overview. Part II. J Am Acad Dermatol 1994; 30: 911-933.
8. Korting HC, Schäfer-Korting M. Is tinea unguium still widely incurable? Arch Dermatol 1992; 128: 243-248.
9. Faergeman J. Zehender H, Denouel J, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks. Acta Derm Venereol (Stockh) 1993; 73: 305-309.
10. Munro C, Shuster S. The route of rapid access of drugs to the distal nail plate. Acta Derm Venereol (Stockh) 1992; 72: 387-388.
11. Finlay AY. Pharmacokinetics of terbinafine in the nail. Br J Dermatol 1992; 126(Suppl. 39): 28-32.
12. Zaias N. Management of onychomycosis with oral terbinafine. J Am Acad Dermatol 1990: 23(Suppl.): 810-812.
13. Goodfields MJD. Short duration therapy with terbinafine for dermatophyte onychomycosis: a multicenter trial. Br J Dermatol 1992; 126(Suppl. 39): 33-35.
14. Baudraz-Rosselet F, Rakasi T, Wili PB, Kenzelman R. Treatment of onychomycosis with terbinafine. Br J Dermatol 1992; 126(Suppl. 39): 40-46.
15. Van der Schroeff JG, Cirkel PKS, Crijns MB, van Dijk TJA. Govaert FJ, Grolneweg DA, et al. A randomized treatment duration-finding study of terbinafine in dermatophytosis. Br J Dermatol 1992; 126(Suppl. 39): 36-39.
16. Cribier B, Grosshans E. Efficalité et tolérance de la terbinafine (Lamisil®) dans une serie de 50 onychomycosis á dermatophytes. Ann Dermatol Venereol 1994; 121: 15-20.
17. Færgeman J, Anderson C, Hersle K, Hradil E, Nordin P, Kaaman T, et al. Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toe nail onychomycosis. J Am Acad Dermatol 1995; 32: 750-753.
18. Haldane DJM, Robert E. A comparison of calcofluor white, potassium hydroxide, and culture for the laboratory diagnosis of superficial fungal infections. Diagn Microbiol Infect Dis 1990; 13: 337-339.
19. Williams TG. Mycological aspects of 118 patients with fungal toenail infections treated with oral terbinafine. XII Congress of ISHAM, Adelaide, Australia.
20. Naka W, Hanyaku H, Tajima S. et al. Application of neutral red staining for evaluation of the viability of dermatophytes and Candida in human skin scales. J Med Vet Mycol 1994; 32: 31-36.
21. McGregor JM, Rustin MHA. Terbinafine and erythema multiforme. [Letter] Br J Dermatol 1994; 131(4): 587-588.
22. Carstens J, Wendelboe P, Søgaard H, Thestrup-Pedersen K. Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine. Acta Derm Venereol (Stockh) 1994; 74: 391-392.